Dinusha Nishani Udukala
Dinusha Nishani Udukala has a total of 19 co-authors. Here are the top co-authors by number of shared publications:
- Medha Jaimini Gunaratna
Department of Chemistry, Faculty of Science, University of Kelaniya, Kelaniya 11600, Sri Lanka
2 shared publications - A. Nethma Wethalawe
Institute of Chemistry Ceylon, College of Chemical Sciences, Rajagiriya 10100, Sri Lanka
1 shared publication - D. A. Upeka Chathurangani
College of Chemical Sciences, Institute of Chemistry Ceylon, Rajagiriya, Sri Jayawardenepura Kotte 10107, Sri Lanka
1 shared publication - D. M. W. S. Dissanayake
College of Chemical Sciences, Institute of Chemistry Ceylon, Rajagiriya, Sri Jayawardenepura Kotte 10107, Sri Lanka
1 shared publication D.A. Upeka Chathurangani
Institute of Chemistry Ceylon, College of Chemical Sciences
1 shared publication- G. Mashooda Jayah
College of Chemical Sciences, Institute of Chemistry Ceylon, Rajagiriya, Sri Jayawardenepura Kotte 10107, Sri Lanka
1 shared publication
Latest Publications
- Open Access
- 16 August 2026
- Published by MDPI AG in Pharmaceutics
- Vol. 18 (8) , 1013
Synthesis and Anti-Diabetic Evaluation of 2-Phenyl-3H-quinazolin-4-one Derivatives
Background/Objectives: Diabetes mellitus is a common endocrine disorder characterized by hyperglycemia, which is increasing steadily all over the world. Current medications are limited due to lower efficacy and side effects; therefore, the introduction of novel compounds is crucial to improve therapeutic outcomes for diabetic patients. The objective of this study was to synthesize and evaluate 2-phenyl-3H-quinazolin-4-one and its derivatives for the glucose uptake across the yeast cell membranes, alpha-amylase inhibition, and alpha-glucosidase inhibition in silico and in vitro. Methods: The synthesis of 2-phenyl-3H-quinazolin-4-one and its derivatives was carried out by oxidative cyclocondensation of 2-aminobenzamide (anthranilamide) with various benzaldehydes in the presence of aqueous iron (III) chloride. The synthesized compounds were characterized by melting point determination and spectroscopic techniques, including FTIR, NMR and HRMS. Results: In the glucose uptake by yeast assay, compound 3f had a lower 50% glucose uptake value of 24.02 ± 0.96 mM, compared with the standard drug metformin (25.99 ± 2.41 mM). The alpha-amylase inhibition bioassay showed that compound 3e exhibited very potent inhibition, with an IC50 of 0.43 ± 0.05 mM, compared with the standard drug acarbose (0.53 ± 0.21 mM). Compound 3l exhibited strong alpha-glucosidase inhibition, with an IC50 of 0.42 ± 0.10 mM, compared with the standard drug acarbose (0.29 ± 0.50 mM). Coclusions: These findings suggest the potential of synthesized 2-phenyl-3H-quinazolin-4-one derivatives, 3a–o, as promising candidates for managing diabetes mellitus. However, further studies are required to validate their efficacy and determine their mechanisms of action.
- 16 August 2026
- Published by MDPI AG in Pharmaceutics
- Vol. 18 (8) , 1013
Open AccessSynthesis and Anti-Diabetic Evaluation of 2-Phenyl-3H-quinazolin-4-one Derivatives
Background/Objectives: Diabetes mellitus is a common endocrine disorder characterized by hyperglycemia, which is increasing steadily all over the world. Current medications are limited due to lower efficacy and side effects; therefore, the introduction of novel compounds is crucial to improve therapeutic outcomes for diabetic patients. The objective of this study was to synthesize and evaluate 2-phenyl-3H-quinazolin-4-one and its derivatives for the glucose uptake across the yeast cell membranes, alpha-amylase inhibition, and alpha-glucosidase inhibition in silico and in vitro. Methods: The synthesis of 2-phenyl-3H-quinazolin-4-one and its derivatives was carried out by oxidative cyclocondensation of 2-aminobenzamide (anthranilamide) with various benzaldehydes in the presence of aqueous iron (III) chloride. The synthesized compounds were characterized by melting point determination and spectroscopic techniques, including FTIR, NMR and HRMS. Results: In the glucose uptake by yeast assay, compound 3f had a lower 50% glucose uptake value of 24.02 ± 0.96 mM, compared with the standard drug metformin (25.99 ± 2.41 mM). The alpha-amylase inhibition bioassay showed that compound 3e exhibited very potent inhibition, with an IC50 of 0.43 ± 0.05 mM, compared with the standard drug acarbose (0.53 ± 0.21 mM). Compound 3l exhibited strong alpha-glucosidase inhibition, with an IC50 of 0.42 ± 0.10 mM, compared with the standard drug acarbose (0.29 ± 0.50 mM). Coclusions: These findings suggest the potential of synthesized 2-phenyl-3H-quinazolin-4-one derivatives, 3a–o, as promising candidates for managing diabetes mellitus. However, further studies are required to validate their efficacy and determine their mechanisms of action.
- Open Access
- 31 December 2024
- Published by Yarmouk University in Jordan Journal of Chemistry (jjc)
- Vol. 19 (3) , 133-157
A Comprehensive Review of The Chemical Composition and Pharmacological Activities of The Genus Dialium
The Dialium genus consists of about 35 recognized species found in tropical regions, which are flowering plants of Leguminosae. However, only a few of the several species in this genus, including D. angolense, D. cochinchinense, D. corbisieri, D. dinklagei, D. excelsum, D. guineense, D. indum, D. ovoideum thwaites, and D. packyphyllum have been the focus of investigation. Traditional systems of medicine are also well aware of the therapeutic benefits of the Dialium genus. Many researchers have investigated the species for its pharmacological properties and medicinal uses, such as antioxidant, anti-microbial, anti-plasmodial, cytotoxic and anti-hepatotoxic, anti-diabetic and anti-inflammatory activities. This report aims to review the recent studies on phytochemistry, pharmacological applications, bioactive compound isolation and identification of the Dialium genus. Thus, the search for reliable therapeutic drugs to address current medical problems led to the development of novel bioresources that met the requirements of researchers.
- 31 December 2024
- Published by Yarmouk University in Jordan Journal of Chemistry (jjc)
- Vol. 19 (3) , 133-157
Open AccessA Comprehensive Review of The Chemical Composition and Pharmacological Activities of The Genus Dialium
The Dialium genus consists of about 35 recognized species found in tropical regions, which are flowering plants of Leguminosae. However, only a few of the several species in this genus, including D. angolense, D. cochinchinense, D. corbisieri, D. dinklagei, D. excelsum, D. guineense, D. indum, D. ovoideum thwaites, and D. packyphyllum have been the focus of investigation. Traditional systems of medicine are also well aware of the therapeutic benefits of the Dialium genus. Many researchers have investigated the species for its pharmacological properties and medicinal uses, such as antioxidant, anti-microbial, anti-plasmodial, cytotoxic and anti-hepatotoxic, anti-diabetic and anti-inflammatory activities. This report aims to review the recent studies on phytochemistry, pharmacological applications, bioactive compound isolation and identification of the Dialium genus. Thus, the search for reliable therapeutic drugs to address current medical problems led to the development of novel bioresources that met the requirements of researchers.
- 1 January 2024
- Published by Diva Enterprises Private Limited in Medicinal Plants - International Journal of Phytomedicines and Related Industries
- Vol. 16 (2) , 350-358
Evaluation of phytochemical composition and biological activities of ethanol extract of bark of Dialium ovoideum thwaites
The present study aimed to investigate the biological activities of the ethanol extract of the bark of Dialium ovoideum Thwaites (DOEB), which is an endemic plant of Sri Lanka with various medicinal values. A powdered bark sample was subjected to soxhlet extraction using ethanol followed by solvent evaporation to obtain the bark extract. The phytochemical screening performed on DOEB revealed the presence of phenols, flavonoids, tannins, saponins, terpenoids and steroids. The total phenolic and flavonoid contents of the DOEB were measured as 233.4±22.7 mg GAE/g and 198.1±24.5 mg QE/g, respectively. The antioxidant activity of DOEB showed an EC50 of 68.5±6.3 µg/mL for the DPPH free radical scavenging assay and a significant (p50 of 1298.3±36.2 µg/mL. The human red blood cell stabilization assay by heat hemolysis resulted in an IC50 of 425.7±9.3 µg/mL. The agar-well diffusion assay was conducted to assess the anti-microbial activities against the Staphylococus aureus, Escherichia coli, Klebsiella pneumoniae bacterial strains and the fungus, Candida albicans. The results exhibited that DOEB inhibited the growth of all three bacteria and fungi in different concentrations. Functional groups analysis of DOEB by FT-IR spectroscopy revealed the presence of alcohols, carboxylic acids, alkanes, alkenes, aliphatic esters, carbonyl and aromatic compounds. This study showed that DOEB has promising bioactivities based on the assays conducted which has a high potential to isolate bioactive compounds. Hence, DOEB may be employed as a prospective candidate in the food and pharmaceutical industries.
- 1 January 2024
- Published by Diva Enterprises Private Limited in Medicinal Plants - International Journal of Phytomedicines and Related Industries
- Vol. 16 (2) , 350-358
Evaluation of phytochemical composition and biological activities of ethanol extract of bark of Dialium ovoideum thwaites
The present study aimed to investigate the biological activities of the ethanol extract of the bark of Dialium ovoideum Thwaites (DOEB), which is an endemic plant of Sri Lanka with various medicinal values. A powdered bark sample was subjected to soxhlet extraction using ethanol followed by solvent evaporation to obtain the bark extract. The phytochemical screening performed on DOEB revealed the presence of phenols, flavonoids, tannins, saponins, terpenoids and steroids. The total phenolic and flavonoid contents of the DOEB were measured as 233.4±22.7 mg GAE/g and 198.1±24.5 mg QE/g, respectively. The antioxidant activity of DOEB showed an EC50 of 68.5±6.3 µg/mL for the DPPH free radical scavenging assay and a significant (p50 of 1298.3±36.2 µg/mL. The human red blood cell stabilization assay by heat hemolysis resulted in an IC50 of 425.7±9.3 µg/mL. The agar-well diffusion assay was conducted to assess the anti-microbial activities against the Staphylococus aureus, Escherichia coli, Klebsiella pneumoniae bacterial strains and the fungus, Candida albicans. The results exhibited that DOEB inhibited the growth of all three bacteria and fungi in different concentrations. Functional groups analysis of DOEB by FT-IR spectroscopy revealed the presence of alcohols, carboxylic acids, alkanes, alkenes, aliphatic esters, carbonyl and aromatic compounds. This study showed that DOEB has promising bioactivities based on the assays conducted which has a high potential to isolate bioactive compounds. Hence, DOEB may be employed as a prospective candidate in the food and pharmaceutical industries.
- Open Access
Synthesis, In Silico Studies, and Evaluation of Syn and Anti Isomers of N-Substituted Indole-3-carbaldehyde Oxime Derivatives as Urease Inhibitors against Helicobacter pylori
Gastrointestinal tract infection caused by Helicobacter pylori is a common virulent disease found worldwide, and the infection rate is much higher in developing countries than in developed ones. In the pathogenesis of H. pylori in the gastrointestinal tract, the secretion of the urease enzyme plays a major role. Therefore, inhibition of urease is a better approach against H. pylori infection. In the present study, a series of syn and anti isomers of N-substituted indole-3-carbaldehyde oxime derivatives was synthesized via Schiff base reaction of appropriate carbaldehyde derivatives with hydroxylamine hydrochloride. The in vitro urease inhibitory activities of those derivatives were evaluated against that of Macrotyloma uniflorum urease using the modified Berthelot reaction. Out of the tested compounds, compound 8 (IC50 = 0.0516 ± 0.0035 mM) and compound 9 (IC50 = 0.0345 ± 0.0008 mM) were identified as the derivatives with potent urease inhibitory activity with compared to thiourea (IC50 = 0.2387 ± 0.0048 mM). Additionally, in silico studies for all oxime compounds were performed to investigate the binding interactions with the active site of the urease enzyme compared to thiourea. Furthermore, the drug-likeness of the synthesized oxime compounds was also predicted.
Open AccessSynthesis, In Silico Studies, and Evaluation of Syn and Anti Isomers of N-Substituted Indole-3-carbaldehyde Oxime Derivatives as Urease Inhibitors against Helicobacter pylori
Gastrointestinal tract infection caused by Helicobacter pylori is a common virulent disease found worldwide, and the infection rate is much higher in developing countries than in developed ones. In the pathogenesis of H. pylori in the gastrointestinal tract, the secretion of the urease enzyme plays a major role. Therefore, inhibition of urease is a better approach against H. pylori infection. In the present study, a series of syn and anti isomers of N-substituted indole-3-carbaldehyde oxime derivatives was synthesized via Schiff base reaction of appropriate carbaldehyde derivatives with hydroxylamine hydrochloride. The in vitro urease inhibitory activities of those derivatives were evaluated against that of Macrotyloma uniflorum urease using the modified Berthelot reaction. Out of the tested compounds, compound 8 (IC50 = 0.0516 ± 0.0035 mM) and compound 9 (IC50 = 0.0345 ± 0.0008 mM) were identified as the derivatives with potent urease inhibitory activity with compared to thiourea (IC50 = 0.2387 ± 0.0048 mM). Additionally, in silico studies for all oxime compounds were performed to investigate the binding interactions with the active site of the urease enzyme compared to thiourea. Furthermore, the drug-likeness of the synthesized oxime compounds was also predicted.
- Open Access
Antimicrobial Compounds Isolated from Endolichenic Fungi: A Review
A lichen is a symbiotic relationship between a fungus and a photosynthetic organism, which is algae or cyanobacteria. Endolichenic fungi are a group of microfungi that resides asymptomatically within the thalli of lichens. Endolichenic fungi can be recognized as luxuriant metabolic artists that produce propitious bioactive secondary metabolites. More than any other time, there is a worldwide search for new antibiotics due to the alarming increase in microbial resistance against the currently available therapeutics. Even though a few antimicrobial compounds have been isolated from endolichenic fungi, most of them have moderate activities, implying the need for further structural optimizations. Recognizing this timely need and the significance of endolichenic fungi as a promising source of antimicrobial compounds, the activity, sources and the structures of 31 antibacterial compounds, 58 antifungal compounds, two antiviral compounds and one antiplasmodial (antimalarial) compound are summarized in this review. In addition, an overview of the common scaffolds and structural features leading to the corresponding antimicrobial properties is provided as an aid for future studies. The current challenges and major drawbacks of research related to endolichenic fungi and the remedies for them have been suggested.
Open AccessAntimicrobial Compounds Isolated from Endolichenic Fungi: A Review
A lichen is a symbiotic relationship between a fungus and a photosynthetic organism, which is algae or cyanobacteria. Endolichenic fungi are a group of microfungi that resides asymptomatically within the thalli of lichens. Endolichenic fungi can be recognized as luxuriant metabolic artists that produce propitious bioactive secondary metabolites. More than any other time, there is a worldwide search for new antibiotics due to the alarming increase in microbial resistance against the currently available therapeutics. Even though a few antimicrobial compounds have been isolated from endolichenic fungi, most of them have moderate activities, implying the need for further structural optimizations. Recognizing this timely need and the significance of endolichenic fungi as a promising source of antimicrobial compounds, the activity, sources and the structures of 31 antibacterial compounds, 58 antifungal compounds, two antiviral compounds and one antiplasmodial (antimalarial) compound are summarized in this review. In addition, an overview of the common scaffolds and structural features leading to the corresponding antimicrobial properties is provided as an aid for future studies. The current challenges and major drawbacks of research related to endolichenic fungi and the remedies for them have been suggested.